TransCode Therapeutics (RNAZ) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO and Chairman, with formal business and notice confirmed for all shareholders of record as of May 28, 2026.

• Jenna Bentley was appointed as Inspector of Election, with her oath and affidavit to be filed with the meeting minutes.

Corporate governance

• A quorum was confirmed to be present in person or by proxy, allowing the meeting to proceed.

• The meeting was adjourned in accordance with amended and restated bylaws to allow for regulatory review.

Shareholder proposals

• Approval of Proposal 1 was postponed pending completion of Nasdaq's review of the initial listing application, as required by Nasdaq Listing Rule 5110.